16-18793379-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_015161.3(ARL6IP1):c.494-9T>A variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0011 in 1,472,622 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0011 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 2 hom. )
Consequence
ARL6IP1
NM_015161.3 splice_polypyrimidine_tract, intron
NM_015161.3 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.0008291
2
Clinical Significance
Conservation
PhyloP100: 1.64
Genes affected
ARL6IP1 (HGNC:697): (ADP ribosylation factor like GTPase 6 interacting protein 1) This gene belongs to the ARL6ip family and encodes a transmembrane protein that is predominantly localized to intracytoplasmic membranes. It is highly expressed in early myeloid progenitor cells and thought to be involved in protein transport, membrane trafficking, or cell signaling during hematopoietic maturation. Mutations in this gene are associated with spastic paraplegia 61 (SPG61). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 16-18793379-A-T is Benign according to our data. Variant chr16-18793379-A-T is described in ClinVar as [Likely_benign]. Clinvar id is 541704.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL6IP1 | NM_015161.3 | c.494-9T>A | splice_polypyrimidine_tract_variant, intron_variant | ENST00000304414.12 | NP_055976.1 | |||
ARL6IP1 | NM_001313858.1 | c.407-9T>A | splice_polypyrimidine_tract_variant, intron_variant | NP_001300787.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARL6IP1 | ENST00000304414.12 | c.494-9T>A | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_015161.3 | ENSP00000306788 | P1 | |||
ARL6IP1 | ENST00000563861.5 | c.*76-9T>A | splice_polypyrimidine_tract_variant, intron_variant, NMD_transcript_variant | 1 | ENSP00000456596 | |||||
ARL6IP1 | ENST00000546206.6 | c.407-9T>A | splice_polypyrimidine_tract_variant, intron_variant | 2 | ENSP00000440048 | |||||
ARL6IP1 | ENST00000562819.5 | c.149-9T>A | splice_polypyrimidine_tract_variant, intron_variant | 5 | ENSP00000457372 |
Frequencies
GnomAD3 genomes AF: 0.00108 AC: 164AN: 151666Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
164
AN:
151666
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000927 AC: 183AN: 197432Hom.: 1 AF XY: 0.000891 AC XY: 96AN XY: 107720
GnomAD3 exomes
AF:
AC:
183
AN:
197432
Hom.:
AF XY:
AC XY:
96
AN XY:
107720
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00111 AC: 1463AN: 1320840Hom.: 2 Cov.: 21 AF XY: 0.00103 AC XY: 681AN XY: 661546
GnomAD4 exome
AF:
AC:
1463
AN:
1320840
Hom.:
Cov.:
21
AF XY:
AC XY:
681
AN XY:
661546
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00108 AC: 164AN: 151782Hom.: 0 Cov.: 33 AF XY: 0.00102 AC XY: 76AN XY: 74216
GnomAD4 genome
AF:
AC:
164
AN:
151782
Hom.:
Cov.:
33
AF XY:
AC XY:
76
AN XY:
74216
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hereditary spastic paraplegia 61 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 19, 2023 | - - |
ARL6IP1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 13, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at